We have clients struggling with the balance of bringing on commercial teams too early and wrestling with the uncertainties of the FDA. In this capacity we can add significant value to the "sprouting" organization without the need for the organization to bring on FTE's. Services we have provided include but are not limited to:
Salesforce sizing, alignments, forecasts
Incentive compensation modeling
Operational support and RFP vendor selection
GTM strategy development
RPO selection process and capability development
Launch excellence team leadership
Our post approval clients have successfully navigated the FDA. While that is quite an achievement, the work is just beginning. We help clients sort out the well intentioned and unavoidable oversights leading up to launch and post launch, ensuring that their organizations are running as efficiently as possible. We help them define, and in some cases, redefine their corporate strategy, help them navigate change associated with shifting deployment of salesforce assets, advise them in new product planning evaluations associated with salesforce execution and more.
The business of developing and commercializing pharmacologic and medical device technology is dynamic. At times, things do not go the way we predict. Our team assists clients in redefining their commercial strategy to help them navigate the significant change that comes with the unexpected. Our team is adept at change management while, at the same time, defining the "needs" versus the "wants" on a go forward. Our significant commercial leadership experience has proven essential for resets and winddowns of operations.